Status
Conditions
Treatments
About
The WHO-PEN@Scale project is a three-arm cluster-randomized trial that is investigating the population-level effects of a healthcare reform in Eswatini, which aims to strengthen primary care for diabetes and hypertension. Prior to the reform, healthcare for diabetes and hypertension was mostly provided through physician-led teams in hospital outpatient departments. The healthcare reform aims to strengthen the provision of nurse-led care for diabetes and hypertension in primary healthcare facilities and community health worker-led care for these conditions in the facilities' catchment areas. The reform will broadly be guided by the World Health Organization's "Package of Essential Noncommunicable Disease Interventions for Primary Health Care in Low-Resource Settings" (WHO-PEN). The trial will take place at 84 clusters (a primary healthcare facility and its catchment area) across the country.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion criteria for the outcome assessment (household survey):
Exclusion criteria for the outcome assessment (household survey):
Primary purpose
Allocation
Interventional model
Masking
3,500 participants in 3 patient groups
Loading...
Central trial contact
Till Bärnighausen, MD ScD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal